跳至主要内容
临床试验/NL-OMON48672
NL-OMON48672已完成4 期

Influence of dose interval on the pharmacokinetics of both unbound and total fractions of clozapine and norclozapine in psychiatric patients in the Netherlands - INPUT study

Albert Schweitzer Ziekenhuis0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Age *18 * 70 years
  • * Clozapine use BID or OID
  • * Capacity to speak and read the Dutch language.
  • * Mental competency and decisional capacity with regard to participation in the current study
  • * Absence of active suicidality
  • * Clozapine use in *steady state* (i.e. same dose and frequency for *7 days)
  • * Signed Informed consent

排除标准

  • * *inbewaringstelling* (IBS)
  • * *rechterlijke machtiging* (RM)
  • * Pregnancy (if known)
  • * Initiation, cessation or dose change of the following co-medication within 7 days prior to blood sampling:
  • o Fluvoxamine
  • o Hormonal anti-conceptive,
  • o Ciprofloxacin,
  • o Phenytoin,
  • o Valproic acid,
  • o Carbamazepine
  • o Rifampicin.
  • * Acute inflammation / infection (derived from having fever (i.e. body temperature >38.0 degrees Celsius and/or using an antibiotic at time of blood sampling).
  • * Smoking (of tobacco containing products) initiation or cessation < 7 days before participation

研究者

相似试验